194 related articles for article (PubMed ID: 9695727)
1. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K
Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
[TBL] [Abstract][Full Text] [Related]
2. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
[TBL] [Abstract][Full Text] [Related]
3. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Tanigawara Y; Okamura N; Hirai M; Yasuhara M; Ueda K; Kioka N; Komano T; Hori R
J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
[TBL] [Abstract][Full Text] [Related]
4. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.
Koren G; Woodland C; Ito S
Vet Hum Toxicol; 1998 Feb; 40(1):45-6. PubMed ID: 9467211
[TBL] [Abstract][Full Text] [Related]
5. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
Hori R; Okamura N; Aiba T; Tanigawara Y
J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
Verschraagen M; Koks CH; Schellens JH; Beijnen JH
Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
[TBL] [Abstract][Full Text] [Related]
8. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
9. Dronedarone-induced digoxin toxicity: new drug, new interactions.
Vallakati A; Chandra PA; Pednekar M; Frankel R; Shani J
Am J Ther; 2013; 20(6):e717-9. PubMed ID: 21519214
[TBL] [Abstract][Full Text] [Related]
10. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin-induced digoxin toxicity: a case report and a review of the literature.
Xu H; Rashkow A
Conn Med; 2001 Sep; 65(9):527-9. PubMed ID: 11678058
[TBL] [Abstract][Full Text] [Related]
12. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature.
Lee CY; Marcotte F; Giraldeau G; Koren G; Juneau M; Tardif JC
Can J Cardiol; 2011; 27(6):870.e15-6. PubMed ID: 21907534
[TBL] [Abstract][Full Text] [Related]
13. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
Westphal K; Weinbrenner A; Zschiesche M; Franke G; Knoke M; Oertel R; Fritz P; von Richter O; Warzok R; Hachenberg T; Kauffmann HM; Schrenk D; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
[TBL] [Abstract][Full Text] [Related]
14. Two cases of clarithromycin-induced digoxin toxicity.
Guerriero SE; Ehrenpreis E; Gallagher KL
Pharmacotherapy; 1997; 17(5):1035-7. PubMed ID: 9324195
[TBL] [Abstract][Full Text] [Related]
15. The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
Woodland C; Verjee Z; Giesbrecht E; Koren G; Ito S
J Pharmacol Exp Ther; 1997 Oct; 283(1):39-45. PubMed ID: 9336306
[TBL] [Abstract][Full Text] [Related]
16. Changes in the pharmacokinetics of digoxin in polyuria in streptozotocin-induced diabetic mice and lithium carbonate-treated mice.
Ikarashi N; Kagami M; Kobayashi Y; Ishii M; Toda T; Ochiai W; Sugiyama K
Xenobiotica; 2011 Jun; 41(6):486-93. PubMed ID: 21319957
[TBL] [Abstract][Full Text] [Related]
17. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
Woodland C; Koren G; Ito S
J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole decreases renal clearance of digoxin.
Jalava KM; Partanen J; Neuvonen PJ
Ther Drug Monit; 1997 Dec; 19(6):609-13. PubMed ID: 9421099
[TBL] [Abstract][Full Text] [Related]
19. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont L; Verstuyft C; Kerb R; Brinkmann U; Lebot M; Jaillon P; Funck-Brentano C
Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
[TBL] [Abstract][Full Text] [Related]
20. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
Tsutsumi K; Kotegawa T; Kuranari M; Otani Y; Morimoto T; Matsuki S; Nakano S
J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
